Advocates Rally Against High HIV Drug Prices at Miami Shareholder Meeting: A Call for Accessible Healthcare

March 25, 2024

#ERROR!

Press Releases

Share this article

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

May 15, 2025

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

May 15, 2025

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

May 14, 2025

Why Experts Are Calling for a Decade-Long Moratorium on Human Germline Editing: Safety, Ethics, and the Future of Gene Therapy

Why Experts Are Calling for a Decade-Long Moratorium on Human Germline Editing: Safety, Ethics, and the Future of Gene Therapy

May 14, 2025

Breaking Barriers: The Rise of Venture Capital in Women’s Health Amidst Federal Challenges

Breaking Barriers: The Rise of Venture Capital in Women’s Health Amidst Federal Challenges

May 14, 2025

Navigating Medicare Drug Price Negotiations: Key Insights from HHS Guidance on Part B Drugs

Navigating Medicare Drug Price Negotiations: Key Insights from HHS Guidance on Part B Drugs

May 13, 2025

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

May 15, 2025

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

May 15, 2025

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

May 14, 2025

Why Experts Are Calling for a Decade-Long Moratorium on Human Germline Editing: Safety, Ethics, and the Future of Gene Therapy

Why Experts Are Calling for a Decade-Long Moratorium on Human Germline Editing: Safety, Ethics, and the Future of Gene Therapy

May 14, 2025

Breaking Barriers: The Rise of Venture Capital in Women’s Health Amidst Federal Challenges

Breaking Barriers: The Rise of Venture Capital in Women’s Health Amidst Federal Challenges

May 14, 2025

Navigating Medicare Drug Price Negotiations: Key Insights from HHS Guidance on Part B Drugs

Navigating Medicare Drug Price Negotiations: Key Insights from HHS Guidance on Part B Drugs

May 13, 2025

Azafaros Raises €146 Million to Propel Phase 3 Trials for Metabolic Disorders: A Game Changer in Biotech

Azafaros Raises €146 Million to Propel Phase 3 Trials for Metabolic Disorders: A Game Changer in Biotech

May 13, 2025

FDA and CDC Suspend Valneva's Ixchiq Vaccine for Seniors: What You Need to Know

FDA and CDC Suspend Valneva’s Ixchiq Vaccine for Seniors: What You Need to Know

May 13, 2025

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA